Athanasios Papadas
Immunology and Microbiology · The Ohio State University
Publications
30
Citations
559
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2017
Athanasios Papadas studies how the supportive tissue (stroma) surrounding tumors, especially a large sugar-protein molecule called versican and its breakdown products, affects immune cells like dendritic cells and CD8+ T cells within the tumor microenvironment. This work has implications for understanding resistance to cancer immunotherapy and for improving treatments in cancers such as multiple myeloma and breast cancer. Much of the research combines mouse models, tissue analysis, and biomarker studies to link stromal remodeling with immune activation against tumors.
Publication output has been relatively modest and fluctuating over the past decade, dipping around 2021 and 2023 but showing a slight uptick again in the most recent years, averaging about 2.6 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 6746: Biomarker-driven restoration of tumor provisional matrix signaling network reverses resistance to checkpoint inhibition immunotherapy
Cancer Research · 2026
- Abstract 2588: Stromal remodeling promotes immune triad formation in the tumor microenvironment (TME)
Cancer Research · 2025
- Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer
Cancers · 2025
- Protocol to identify and isolate rare murine tumor-resident dendritic cell populations for low-input transcriptomic profiling
STAR Protocols · 2024
- Abstract 4210: Stromal remodeling danger signals regulate “second-touch” antigenic encounters and promote CD8+ T cell effector differentiation in the TME
Cancer Research · 2024
- Correction: Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity
Biochemical Society Transactions · 2024
- Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity
Biochemical Society Transactions · 2023
- 981 Peritumoral stromal remodeling licenses cDC1 through CD40 to elicit T-cell inflammation
Regular and Young Investigator Award Abstracts · 2022
- Versican in Tumor Progression, Tumor–Host Interactions, and Cancer Immunotherapy
Biology of extracellular matrix · 2022
- Matrix proteoglycans in tumor inflammation and immunity
American Journal of Physiology-Cell Physiology · 2022
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
Cell Reports · 2022
- 936 Stromal remodeling regulates dendritic cell abundance in the tumor microenvironment
Regular and Young Investigator Award Abstracts · 2021
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Abstract 5733: Versican proteolytic fragments (matrikines) synergize with STING agonists to elicit robust anti-tumor CD8+ T cell responses
Cancer Research · 2020
- Versican in the Tumor Microenvironment
Advances in experimental medicine and biology · 2020
- Blood×5
- Cancer Research×4
- The Journal of Immunology×2
- Biochemical Society Transactions×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Louise Carlson
Immunology and Microbiology · Indiana University
- Aki Hoji
Immunology and Microbiology · Indiana University
- Diana M. Lopez
Immunology and Microbiology · The Ohio State University
- Jay Overholser
Immunology and Microbiology · Indiana University
- Megan Hill
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile